Investor Class Action Over AstraZeneca COVID-19 Drug Dismissed With Prejudice
NEW YORK — A federal judge in New York on Sept. 12 ruled that shareholders in a class action against biopharmaceutical company AstraZeneca PLC and certain of its senior officials, who...To view the full article, register now.
Already a subscriber? Click here to view full article